Company Filing History:
Years Active: 2017-2020
Title: Lenka Koci: Innovator in Cancer Immunotherapy
Introduction
Lenka Koci is a prominent inventor based in Brno, Czech Republic. She has made significant contributions to the field of cancer immunotherapy, holding a total of 4 patents. Her innovative work focuses on the cryopreservation of apoptotic cancer cells, which has the potential to revolutionize cancer treatment.
Latest Patents
One of Lenka Koci's latest patents is titled "Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer." This patent describes a reliable method for preparing a potent vaccine useful for immunotherapy. The method involves cryopreserving a population of cells undergoing immunogenic cell death and using these cells to activate dendritic cells for immunotherapy. Specifically, the method comprises cryopreserving cancer cells that are undergoing cell death, which can then be utilized to prepare a pharmaceutical composition for immunotherapy against cancer.
Career Highlights
Lenka Koci is currently associated with Sotio a.s., where she continues to advance her research in cancer immunotherapy. Her work has garnered attention for its innovative approach to utilizing apoptotic cancer cells in therapeutic applications.
Collaborations
Lenka collaborates with notable colleagues, including Jitka Fucikova and Katerina Pokorna. Their combined expertise contributes to the ongoing research and development in the field of immunotherapy.
Conclusion
Lenka Koci's contributions to cancer immunotherapy through her innovative patents and collaborative efforts highlight her as a key figure in the fight against cancer. Her work promises to enhance the effectiveness of immunotherapy treatments, offering hope for improved patient outcomes.